DVA: second_quarter 2026 lobbying report

{"url":"https://lda.gov/api/v1/filings/364d0551-73b7-45ed-9829-3a3a6075ecaf/","filing_uuid":"364d0551-73b7-45ed-9829-3a3a6075ecaf","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/364d0551-73b7-45ed-9829-3a3a6075ecaf/print/","filing_document_content_type":"text/html","income":"20000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Andrew Jones","dt_posted":"2026-07-14T20:50:32-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"5000 Thayer Center STE C","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Oakland","registrant_state":"MD","registrant_zip":"21550","registrant":{"id":401108977,"url":"https://lda.gov/api/v1/registrants/401108977/","house_registrant_id":56708,"name":"APOLLO GOVERNMENT RELATIONS (D/B/A APOLLO COUNSEL)","description":null,"address_1":"5000 Thayer Center STE C","address_2":null,"address_3":null,"address_4":null,"city":"Oakland","state":"MD","state_display":"Maryland","zip":"21550","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ANDREW JONES","contact_telephone":"+1 202-276-3058","dt_updated":"2026-10-19T15:45:02.308569-04:00"},"client":{"id":63474,"url":"https://lda.gov/api/v1/clients/63474/","client_id":63474,"name":"DAVITA, INC","general_description":"Healthcare","client_government_entity":null,"client_self_select":false,"state":"CO","state_display":"Colorado","country":"US","country_display":"United States of America","ppb_state":"CO","ppb_state_display":"Colorado","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2024-09-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"HR 2199/S 1173, Restore Protections for Dialysis Patients Act Issues related to access to treatment for End Stage Renal Disease (ESRD)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":148186,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"JONES","suffix":null,"suffix_display":null},"covered_position":"Legislative Director, Rep. Ben Ray Lujan; Legislative Counsel, Rep. Ruben Hinojosa","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"HR 2199/S 1173, the Restore Protections for Dialysis Patients Act CMS Kidney Care Choices model Issues related to reimbursement for treatment of End Stage Renal Disease (ESRD)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":148186,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"JONES","suffix":null,"suffix_display":null},"covered_position":"Legislative Director, Rep. Ben Ray Lujan; Legislative Counsel, Rep. Ruben Hinojosa","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}